- Germany's Asta Medica sets up in the Ukraine

5 May 1996

- Germany's Asta Medica, a subsidiary of Degussa, has set up a new company in the Ukraine. From its Dresden headquarters, Asta Medica (see also page 26) has opened up in seven eastern European countries over the last two years, and a further company in Riga, Baltic Republic, is near completion. The firm hopes for a brisk development of the privately-financed pharmaceutical market in the Ukraine, which not only compares in surface size to Russia but also has a 52 million population (ie, similar to France). Initially, Asta Medica will offer for sale drugs to treat cardiovascular, cancer and respiratory diseases, but at a later stage will set up its own self-medication business.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight